After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.

在致方案后，将免疫抑制剂从宿主撤离，宿主仍对在原上的免疫原性表位的特异性免疫。

E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.

包括高变区的E2蛋白含有中和性抗原表位，诱导机体产生中和性抗体。